ACAD
ACADIADNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
ACAD vs peer average
46/100
ACAD vs. peer average (D vs. D)
Grade spread
A 1 · B 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ARQT is the first available peer comparator.
Similar-market-cap commercial biopharma comparator, but its dermatology focus makes it a loose operating peer rather than a direct neuroscience valuation benchmark.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACAD
ACADIA
ARQT
Arcutis Biotherapeutics
Grade
D
D
Momentum
6
97
Value
62
55
Sentiment
43
32
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ARQT
ACAD / ARQT
Grade Position
In line
ACAD vs. peer average (D vs. D)
46/100
Momentum
6
ARQTValue
62
ACADSentiment
43
ACADRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACAD
ARQT is the first peer returned for this comparison set.